Amphastar Pharmaceuticals, Inc. (AMPH) shareholders
Close on Nov 16, 2026Market cap $1.24BP/E 17.2Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Jack Y. Zhang Joint filing with Mary Z. Luo (24.80%), Applied Physics & Chemistry Laboratories, Inc. (14.20%) | 12,524,153 | 24.80% | 13G (passive) amendment | Dec 31, 2024 |
| BlackRock, Inc. | 5,333,463 | 11.50% | 13G (passive) amendment | Sep 30, 2025 |
| Dimensional Fund Advisors LP | 2,305,107 | 5.20% | 13G (passive) | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of AMPH | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 5,224,934 | 12.28% | $105.44M | −196,409 | 0.00% |
| Dimensional Fund Advisors LP | 2,305,107 | 5.42% | $46.52M | +277,160 | 0.01% |
| State Street Corp | 1,642,126 | 3.86% | $33.14M | +34,611 | 0.00% |
| Vanguard Capital Management LLC | 1,481,952 | 3.48% | $29.91M | −61,703 | 0.00% |
| American Century Companies Inc | 1,176,626 | 2.77% | $23.74M | +159,088 | 0.01% |
| Marshall Wace, Llp | 1,066,322 | 2.51% | $21.52M | +40,682 | 0.02% |
| Geode Capital Management, LLC | 969,840 | 2.28% | $19.58M | −6,810 | 0.00% |
| Fuller & Thaler Asset Management, Inc. | 949,238 | 2.23% | $19.16M | −445,901 | 0.05% |
| D. E. Shaw & Co., Inc. | 887,048 | 2.09% | $17.90M | +221,506 | 0.01% |
| Vanguard Portfolio Management LLC | 809,568 | 1.90% | $16.34M | +21,752 | 0.00% |
| Lsv Asset Management | 642,014 | 1.51% | $12.96M | −9,700 | 0.02% |
| Renaissance Technologies LLC | 525,100 | 1.23% | $10.60M | −28,800 | 0.01% |
| Goldman Sachs Group Inc | 505,360 | 1.19% | $10.20M | +175,972 | 0.00% |
| Systematic Financial Management LP | 437,384 | 1.03% | $8.83M | −15,514 | 0.18% |
| Morgan Stanley | 434,840 | 1.02% | $8.78M | +14,503 | 0.00% |
| UBS Group AG | 393,110 | 0.92% | $7.93M | −27,153 | 0.00% |
| Hrt Financial LP | 387,530 | 0.91% | $7.82M | +331,349 | 0.00% |
| Denali Advisors LLC | 375,965 | 0.88% | $7.59M | +109,500 | 0.76% |
| Northern Trust Corp | 370,991 | 0.87% | $7.49M | −1,288 | 0.00% |
| Bridge City Capital, LLC | 338,708 | 0.80% | $6.84M | +3,603 | 1.56% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 210 | 28M | 66.6% | 33 / 64 | 75 / 33 | 3M | 7M |
| Q1 2026 | 215 | 32M | 76.0% | 29 / 68 | 96 / 45 | 6M | 6M |
| Q4 2025 | 236 | 35M | 82.3% | 26 / 95 | 86 / 32 | 5M | 3M |
| Q3 2025 | 243 | 33M | 77.6% | 34 / 83 | 92 / 34 | 4M | 4M |
| Q2 2025 | 245 | 33M | 77.7% | 45 / 91 | 73 / 40 | 4M | 5M |
| Q1 2025 | 241 | 33M | 78.2% | 33 / 80 | 95 / 50 | 4M | 6M |
| Q4 2024 | 263 | 35M | 82.7% | 36 / 84 | 100 / 50 | 4M | 4M |
| Q3 2024 | 279 | 36M | 83.5% | 43 / 99 | 93 / 32 | 10M | 3M |
| Q2 2024 | 269 | 34M | 81.0% | 38 / 99 | 101 / 38 | 3M | 4M |
| Q1 2024 | 271 | 35M | 81.9% | 47 / 89 | 98 / 53 | 4M | 3M |
| Q4 2023 | 277 | 34M | 79.9% | 48 / 99 | 91 / 24 | 5M | 3M |
| Q3 2023 | 256 | 32M | 75.2% | 41 / 90 | 93 / 28 | 2M | 2M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
249 funds held AMPH in Q2 2026, 60% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of AMPH | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 2,045,920 | 4.81% | $41.29M | 0.04% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 1,055,676 | 2.48% | $21.30M | 0.00% | Jun 30, 2026 |
| Avantis U.S. Small Cap Value ETF | 945,543 | 2.22% | $17.82M | 0.07% | May 31, 2026 |
| Fullerthaler Behavioral Small Cap Equity | 902,737 | 2.12% | $18.22M | 0.14% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 847,727 | 1.99% | $17.11M | 0.02% | Jun 30, 2026 |
| U.S. Small Cap Value Portfolio | 596,077 | 1.40% | $11.89M | 0.06% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 391,083 | 0.92% | $7.89M | 0.01% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 353,885 | 0.83% | $7.06M | 0.02% | Jul 31, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF | 306,646 | 0.72% | $6.19M | 0.04% | Jun 30, 2026 |
| iShares Russell 2000 Value ETF | 303,954 | 0.71% | $6.13M | 0.04% | Jun 30, 2026 |
| Dimensional U.S. Targeted Value ETF | 285,363 | 0.67% | $5.69M | 0.04% | Jul 31, 2026 |
| U.S. Targeted Value Portfolio | 276,227 | 0.65% | $5.51M | 0.03% | Jul 31, 2026 |
| Vanguard Tax-Managed Small-Cap Fund | 269,433 | 0.63% | $5.44M | 0.05% | Jun 30, 2026 |
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF | 265,621 | 0.62% | $5.36M | 1.25% | Jun 30, 2026 |
| Dimensional US Small Cap Value ETF | 256,428 | 0.60% | $5.11M | 0.06% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| William J. Peters | CFO, EVP & TREASURER, Director | 167,076 | 0.39% | Nov 6, 2026 |
| Jack Y. Zhang | CEO & CHIEF SCIENTIFIC OFFICER, Director, 10% owner | 4,235,177 | 9.96% | Mar 17, 2026 |
| Mary Z. Luo | COO, Chief Scientist, Chairman, Director, 10% owner | 4,014,083 | 9.44% | Mar 17, 2026 |
| Yakob Liawatidewi | EVP CORP ADMIN CENTER, Director | 124,351 | 0.29% | Mar 17, 2026 |
| Rong Zhou | SENIOR EVP, PRODUCTION CENTER | 278,871 | 0.66% | Sep 17, 2026 |
| Richard K. Prins | Director | 29,625 | 0.07% | Aug 12, 2026 |
| Anthony T. Pierce | Director | 7,886 | 0.02% | Jul 13, 2026 |
| Diane G. Gerst | Director | 31,899 | 0.07% | Jun 3, 2026 |
| David Russell Gaugh | Director | 14,447 | 0.03% | Jun 3, 2026 |
| Howard Lee | Director | 159,350 | 0.37% | Jun 3, 2026 |
| Michael A. Zasloff | Director | 37,667 | 0.09% | Jun 3, 2026 |
| Gayle Deflin | Director | 19,057 | 0.04% | Jun 3, 2026 |
| Floyd F. Petersen | Director | 71,368 | 0.17% | Dec 15, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| William J. Peters CFO, EVP & TREASURER, Director | Nov 5, 2026 | Sale(10b5-1 plan) | −12,631 | $28.99 | $366.19K | 167,076 |
| William J. Peters CFO, EVP & TREASURER, Director | Nov 5, 2026 | Option exercise | +11,000 | $17.99 | $197.89K | 179,707 |
| William J. Peters CFO, EVP & TREASURER, Director | Nov 4, 2026 | Sale(10b5-1 plan) | −16,000 | $28.03 | $448.48K | 168,707 |
| William J. Peters CFO, EVP & TREASURER, Director | Nov 4, 2026 | Option exercise | +16,000 | $13.03 | $208.48K | 184,707 |
| William J. Peters CFO, EVP & TREASURER, Director | Sep 21, 2026 | Sale(10b5-1 plan) | −4,139 | $25.00 | $103.48K | 168,707 |
| Rong Zhou SENIOR EVP, PRODUCTION CENTER | Sep 16, 2026 | Option exercise | +10,000 | $13.35 | $133.50K | 179,203 |
| Rong Zhou SENIOR EVP, PRODUCTION CENTER | Sep 16, 2026 | Sale | −10,000 | $23.94 | $239.40K | 169,203 |
| Rong Zhou SENIOR EVP, PRODUCTION CENTER | Sep 2, 2026 | Sale | −3,187 | $23.63 | $75.31K | 169,203 |
| Richard K. Prins Director | Aug 11, 2026 | Sale | −7,973 | $20.30 | $161.85K | 29,625 |
| William J. Peters CFO, EVP & TREASURER, Director | Aug 7, 2026 | Sale(10b5-1 plan) | −8,180 | $22.48 | $183.89K | 172,846 |
| William J. Peters CFO, EVP & TREASURER, Director | Aug 7, 2026 | Option exercise | +5,053 | $19.79 | $100.00K | 181,026 |
| Anthony T. Pierce Director | Jul 9, 2026 | Award | +7,886 | – | – | 7,886 |
| Howard Lee Director | Jun 2, 2026 | Tax withholding | −769 | $18.45 | $14.19K | 159,350 |
| David Russell Gaugh Director | Jun 1, 2026 | Award | +8,143 | – | – | 14,447 |
| Howard Lee Director | Jun 1, 2026 | Award | +8,143 | – | – | 160,119 |
| Michael A. Zasloff Director | Jun 1, 2026 | Award | +8,143 | – | – | 37,667 |
| Diane G. Gerst Director | Jun 1, 2026 | Award | +8,143 | – | – | 31,899 |
| Gayle Deflin Director | Jun 1, 2026 | Award | +8,143 | – | – | 19,057 |
| Richard K. Prins Director | Jun 1, 2026 | Award | +8,143 | – | – | 37,598 |
| Jack Y. Zhang CEO & CHIEF SCIENTIFIC OFFICER, Director, 10% owner | Mar 15, 2026 | Tax withholding | −2,908 | $18.18 | $52.87K | 1,245,125 |
| Jack Y. Zhang CEO & CHIEF SCIENTIFIC OFFICER, Director, 10% owner | Mar 15, 2026 | Tax withholding | −9,784 | $18.18 | $177.87K | 2,990,052 |
| Rong Zhou SENIOR EVP, PRODUCTION CENTER | Mar 15, 2026 | Tax withholding | −1,225 | $18.18 | $22.27K | 171,554 |
| Yakob Liawatidewi EVP CORP ADMIN CENTER, Director | Mar 15, 2026 | Tax withholding | −1,033 | $18.18 | $18.78K | 121,892 |
| William J. Peters CFO, EVP & TREASURER, Director | Mar 15, 2026 | Tax withholding | −1,973 | $18.18 | $35.87K | 175,063 |
| Jack Y. Zhang CEO & CHIEF SCIENTIFIC OFFICER, Director, 10% owner | Mar 10, 2026 | Tax withholding | −14,785 | $18.91 | $279.58K | 2,999,836 |
| Jack Y. Zhang CEO & CHIEF SCIENTIFIC OFFICER, Director, 10% owner | Mar 10, 2026 | Tax withholding | −4,395 | $18.91 | $83.11K | 1,248,033 |
| Yakob Liawatidewi EVP CORP ADMIN CENTER, Director | Mar 10, 2026 | Tax withholding | −1,870 | $18.91 | $35.36K | 122,925 |
| William J. Peters CFO, EVP & TREASURER, Director | Mar 10, 2026 | Tax withholding | −3,297 | $18.91 | $62.35K | 177,036 |
| Rong Zhou SENIOR EVP, PRODUCTION CENTER | Mar 10, 2026 | Tax withholding | −2,215 | $18.91 | $41.89K | 172,779 |
| Jack Y. Zhang CEO & CHIEF SCIENTIFIC OFFICER, Director, 10% owner | Mar 9, 2026 | Award | +72,462 | – | – | 1,252,428 |
| Jack Y. Zhang CEO & CHIEF SCIENTIFIC OFFICER, Director, 10% owner | Mar 9, 2026 | Award | +180,504 | – | – | 3,014,621 |
| Yakob Liawatidewi EVP CORP ADMIN CENTER, Director | Mar 9, 2026 | Award | +35,450 | – | – | 124,795 |
| William J. Peters CFO, EVP & TREASURER, Director | Mar 9, 2026 | Award | +58,693 | – | – | 180,333 |
| Rong Zhou SENIOR EVP, PRODUCTION CENTER | Mar 9, 2026 | Award | +39,432 | – | – | 174,994 |
| Mary Z. Luo COO, Chief Scientist, Chairman, Director, 10% owner | Mar 6, 2026 | Tax withholding | −7,773 | $19.34 | $150.33K | 2,834,117 |
| Mary Z. Luo COO, Chief Scientist, Chairman, Director, 10% owner | Mar 6, 2026 | Tax withholding | −3,077 | $19.34 | $59.51K | 1,179,966 |
| William J. Peters CFO, EVP & TREASURER, Director | Mar 6, 2026 | Tax withholding | −2,146 | $19.34 | $41.50K | 121,640 |
| Yakob Liawatidewi EVP CORP ADMIN CENTER, Director | Mar 6, 2026 | Tax withholding | −1,144 | $19.34 | $22.12K | 89,345 |
| Rong Zhou SENIOR EVP, PRODUCTION CENTER | Mar 6, 2026 | Tax withholding | −1,357 | $19.34 | $26.24K | 135,562 |
| Yakob Liawatidewi EVP CORP ADMIN CENTER, Director | Mar 4, 2026 | Tax withholding | −965 | $19.96 | $19.26K | 90,489 |
| Rong Zhou SENIOR EVP, PRODUCTION CENTER | Mar 4, 2026 | Tax withholding | −1,124 | $19.96 | $22.44K | 136,919 |
| Jack Y. Zhang CEO & CHIEF SCIENTIFIC OFFICER, Director, 10% owner | Mar 4, 2026 | Tax withholding | −2,432 | $19.96 | $48.54K | 1,183,043 |
| Jack Y. Zhang CEO & CHIEF SCIENTIFIC OFFICER, Director, 10% owner | Mar 4, 2026 | Tax withholding | −5,769 | $19.96 | $115.15K | 2,841,890 |
| William J. Peters CFO, EVP & TREASURER, Director | Mar 4, 2026 | Tax withholding | −1,744 | $19.96 | $34.81K | 123,786 |
| Rong Zhou SENIOR EVP, PRODUCTION CENTER | Dec 17, 2025 | Sale | −9,787 | $26.20 | $256.42K | 138,043 |
| Rong Zhou SENIOR EVP, PRODUCTION CENTER | Dec 17, 2025 | Option exercise | +9,787 | $11.33 | $110.89K | 147,830 |
| Floyd F. Petersen Director | Dec 12, 2025 | Sale | −2,426 | $25.92 | $62.88K | 71,368 |
| Floyd F. Petersen Director | Dec 11, 2025 | Sale | −1,737 | $25.69 | $44.62K | 73,794 |
| Richard K. Prins Director | Nov 25, 2025 | Option exercise | +4,179 | $16.69 | $69.75K | 39,362 |
| Richard K. Prins Director | Nov 25, 2025 | Sale | −4,179 | $27.10 | $113.25K | 35,183 |
| Floyd F. Petersen Director | Nov 13, 2025 | Option exercise | +16,679 | $16.69 | $278.37K | 92,210 |
| Floyd F. Petersen Director | Nov 13, 2025 | Sale | −16,679 | $26.49 | $441.83K | 75,531 |
| Floyd F. Petersen Director | Nov 3, 2025 | Sale(10b5-1 plan) | −500 | $25.27 | $12.64K | 75,531 |
| Floyd F. Petersen Director | Oct 1, 2025 | Sale(10b5-1 plan) | −500 | $27.20 | $13.60K | 76,031 |
| Floyd F. Petersen Director | Sep 2, 2025 | Sale(10b5-1 plan) | −500 | $30.98 | $15.49K | 76,531 |
| Floyd F. Petersen Director | Aug 1, 2025 | Sale(10b5-1 plan) | −500 | $20.83 | $10.42K | 77,031 |
| David Russell Gaugh Director | Jul 18, 2025 | Award | +6,304 | – | – | 6,304 |
| Floyd F. Petersen Director | Jul 2, 2025 | Sale(10b5-1 plan) | −500 | $23.47 | $11.74K | 77,531 |
| Jack Y. Zhang CEO & CHIEF SCIENTIFIC OFFICER, Director, 10% owner | Jun 13, 2025 | Option exercise | +200,000 | $13.03 | $2.61M | 2,847,659 |
| Howard Lee Director | Jun 3, 2025 | Tax withholding | −923 | $26.01 | $24.01K | 151,976 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Amphastar Pharmaceuticals's stock actually held short. Settlement fails (shares not delivered on time) peaked at 13,708 shares on Aug 20, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| William J. Peters Officer | Nov 5, 2026 | 12,631 | $366.19K | Nov 5, 2026 | Exercise of Stock Options |
| William J. Peters Officer | Nov 4, 2026 | 16,000 | $448.48K | Nov 4, 2026 | Exercise of Stock Options |
| William J. Peters Officer | Sep 21, 2026 | 4,139 | $103.48K | Sep 21, 2026 | RSU Vesting |
| Rong Zhou Vice President | Sep 1, 2026 | 13,187 | $290.11K | Sep 1, 2026 | Option Exercise |
| Floyd F. Petersen Director | Aug 18, 2026 | 47,101 | $989.12K | Aug 18, 2026 | Option Exercise |
| Richard K. Prins Director | Aug 11, 2026 | 7,973 | $161.93K | Aug 11, 2026 | RSU Vesting |
| William J. Peters Officer | Aug 7, 2026 | 8,180 | $183.89K | Aug 7, 2026 | RSU Vesting |
| Floyd F. Petersen Director | Dec 11, 2025 | 4,163 | $333.04K | Dec 11, 2025 | RSU Vesting |
| Floyd F. Petersen Director | Dec 10, 2025 | 1,737 | $43.43K | Dec 10, 2025 | RSU Vesting |
| Rong Zhou Officer | Nov 28, 2025 | 20,000 | $500.00K | Nov 28, 2025 | Stock Option Exercising |
| Richard K. Prins Director | Nov 25, 2025 | 4,179 | $104.48K | Nov 25, 2025 | Stock Option Exercising |
| Floyd F. Petersen Director | Nov 13, 2025 | 16,679 | $441.84K | Nov 13, 2025 | Stock Option Exercise |
| Floyd F. Petersen Director | Nov 3, 2025 | 500 | $12.65K | Nov 3, 2025 | RSU |
| Floyd F. Petersen Director | Oct 1, 2025 | 500 | $13.37K | Oct 1, 2025 | RSU |
| Floyd F. Petersen Director | Sep 2, 2025 | 500 | $15.45K | Sep 2, 2025 | RSU |
See a number that looks wrong?